{"id":514113,"date":"2020-10-28T07:56:01","date_gmt":"2020-10-28T07:56:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=514113"},"modified":"2020-10-28T07:56:01","modified_gmt":"2020-10-28T07:56:01","slug":"germany-pharmaceuticals-market-size-to-touch-659-billion-by-2027-owing-to-growing-prevalence-of-chronic-diseases-and-rising-expenditure-on-research-and-development-million-insights","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/germany-pharmaceuticals-market-size-to-touch-659-billion-by-2027-owing-to-growing-prevalence-of-chronic-diseases-and-rising-expenditure-on-research-and-development-million-insights_514113.html","title":{"rendered":"Germany Pharmaceuticals Market Size To Touch $65.9 Billion By 2027 Owing To Growing Prevalence of Chronic Diseases And Rising Expenditure on Research and Development | Million Insights"},"content":{"rendered":"
\"Germany<\/a><\/p>\n
\n
Million Insights – World’s Fastest Growing Market Research Database<\/div>\n<\/div>\n<\/div>\n
According to new report available with Million Insights, the Germany pharmaceutical industry report provides a detailed analysis of market size, regional and country-level market size, competitive landscape, impact of domestic market players and value chain optimization. Germany Pharmaceuticals Market is segmented by types, manufacturers, application.\n<\/div>\n

The Germany Pharmaceuticals Market<\/a> <\/strong>size is projected to touch USD 65.9 billion by 2027, according to a new report by Million Insights. The market is anticipated to register 6.0% CAGR over the forecast duration. Growing prevalence of chronic diseases and rise on the expenditure on research and development are attributing to the growth of the market.<\/p>\n

In addition, an increasing number of clinical trials for novel immune-suppressive therapies is projected to bode well for the growth of the market. For example, Sandoz International GmbH introduced Dailiport capsules in June 2020 in European countries including Germany.<\/p>\n

To download the sample pdf of Germany Pharmaceuticals Market Report “Please” click here <\/strong>https:\/\/www.millioninsights.com\/industry-reports\/germany-pharmaceuticals-market\/request-sample<\/strong><\/a><\/p>\n

\"\"<\/strong><\/p>\n

Major market participants are increasingly focusing on strategic initiatives such as merger & acquisition, partnerships and collaboration to consolidate their market presence. For example, Bristol-Myers Squibb made an acquisition of Celgene Corporation in 2019 to expand its product portfolio in oncology.<\/p>\n

The rising availability of cost-effective generic drugs is projected to fuel market growth over the next few years. German companies are focusing on introducing the generic drug to consolidate their market presence. For example, Sandoz of Novartis AG, in mid-2019, introduced gefitinib’s generic version.<\/p>\n

To browse report summary & detailed TOC, “please” click the link below:<\/strong>
https:\/\/www.millioninsights.com\/industry-reports\/germany-pharmaceuticals-market<\/strong><\/a><\/p>\n

\"\"<\/strong><\/p>\n

Further key findings from the report suggest:<\/strong><\/p>\n

• Anti-cancer segment held the largest share in the market in 2019. Approval of the number of drugs and increasing research in the treatment of cancer are attributing to the growth of the Germany pharmaceutical market.<\/p>\n

• By drug class, Immunosuppressant is projected to exhibit the highest growth over the forecast duration.<\/p>\n

• In 2019, the oncology segment occupied the highest share in the market owing to the growing prevalence of prostate cancer, lung cancer and breast cancer.<\/p>\n

• Based on type, generic drug division is projected to exhibit the highest growth over the forecast duration.<\/p>\n

Million Insights has segmented the Germany pharmaceuticals market on the basis of drug class, application, type, and formulation:<\/strong><\/p>\n

Germany Pharmaceuticals Drug Class Outlook (Revenue, USD Million, 2016 – 2027)<\/strong>
    • Anti-cancer
    • Anti-diabetics
    • Anti-rheumatics
    • Vaccines
    • Anti-viral
    • Immunosuppressant
    • Bronchodilators
    • Dermatological
    • Anti-hypertensive
    • Others<\/p>\n

Germany Pharmaceuticals Application Outlook (Revenue, USD Million, 2016 – 2027)<\/strong>
    • Oncology
        • Breast cancer
        • Lung cancer
        • Colorectal cancer
        • Ovarian cancer
        • Prostate cancer
        • Others
    • Infectious Diseases
    • Cardiovascular Diseases
    • Central Nervous System Disorders
    • Immunological Disorders
    • Metabolic Disorders
    • Gastrointestinal Disorders
    • Respiratory Diseases
    • Ophthalmology
    • Dermatology Disorders
    • Others<\/p>\n

Germany Pharmaceuticals Type Outlook (Revenue, USD Million, 2016 – 2027)<\/strong>
    • Branded
    • Generics<\/p>\n

Germany Pharmaceuticals Formulation Outlook (Revenue, USD Million, 2016 – 2027)<\/strong>
    • Solid formulation
        • Tablets
        • Capsules
        • Others
    • Liquid & semi-liquid formulation
        • Oral
        • Topical
        • Sublingual and buccal
        • Rectal
        • Parenteral<\/p>\n

List of Key Players of Germany Pharmaceuticals Market<\/strong>
• Boehringer Ingelheim International GmbH
• Bayer AG
• Merck & Co., Inc.
• Fresenius Kabi AG
• STADA Arzneimittel AG
• Pfizer Inc.
• Abbott
• Abbvie Inc.
• Teva Pharmaceutical Industries Ltd.
• Novartis AG
• Sanofi
• Johnson & Johnson Services, Inc.
• GlaxoSmithKline plc
• AstraZeneca
• Celgene Corporation
• Amgen Inc.
• Novo Nordisk A\/S
• Eli Lilly and Company
• Allergan<\/p>\n

Read the Latest Market Research Reports by Million Insights:<\/strong><\/p>\n

• Aluminum Curtain Wall Market<\/strong><\/a>: <\/strong>The global aluminum curtain wall market size was USD 31.9 billion in 2019. It is anticipated to witness 9.6% CAGR over the forecast duration, 2020 to 2027. Increasing focus on securing the wall outside in businesses premises is driving the product growth.<\/p>\n

• Fuel Cell Market<\/strong><\/a>:<\/strong> The global fuel cell market size was USD 10.48 billion in 2019. The market is estimated to expand at 15.5% CAGR from 2020 to 2027. Rising demand for unconventional energy source is fueling the product demand. Further, increasing partnerships between private and public authorities are anticipated to supplement product demand.<\/p>\n

About Million Insights<\/strong><\/p>\n

Million Insights, is a distributor of market research reports, published by premium publishers only. We have a comprehensive market place that will enable you to compare data points, before you make a purchase. Enabling informed buying is our motto and we strive hard to ensure that our clients get to browse through multiple samples, prior to an investment. Service flexibility & the fastest response time are two pillars, on which our business model is founded. Our market research report store, includes in-depth reports, from across various industry verticals, such as healthcare, technology, chemicals, food & beverages, consumer goods, material science & automotive.<\/p>\n

Media Contact<\/span>
Company Name:<\/strong> Million Insights<\/a>
Contact Person:<\/strong> Ryan Manuel
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> 91-20-65300184
Address:<\/strong>Office No. 302, 3rd Floor, Manikchand Galleria, Model Colony, Shivaji Nagar
City:<\/strong> Pune
State:<\/strong> Maharashtra
Country:<\/strong> India
Website:<\/strong> https:\/\/www.millioninsights.com\/industry-reports\/germany-pharmaceuticals-market<\/a><\/p>\n

<\/object>\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

Million Insights – World’s Fastest Growing Market Research Database According to new report available with Million Insights, the Germany pharmaceutical industry report provides a detailed analysis of market size, regional and country-level market size, competitive landscape, impact of domestic market … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,435,405,417,406],"tags":[],"class_list":["post-514113","post","type-post","status-publish","format-standard","hentry","category-Business","category-Europe","category-Health-Medicine","category-Marketing-Sales","category-Pharmaceuticals-Biotech"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/514113","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=514113"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/514113\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=514113"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=514113"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=514113"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}